SYNJ2BP inhibitors are a class of chemical compounds that specifically target and inhibit the function of the SYNJ2BP protein, also known as synaptojanin-2 binding protein. SYNJ2BP is a mitochondrial outer membrane protein that plays an important role in various cellular processes, including mitochondrial dynamics and cellular signaling. SYNJ2BP interacts with synaptojanin-2, a phosphoinositide phosphatase involved in membrane trafficking and phosphoinositide metabolism. Additionally, SYNJ2BP is known to participate in protein-protein interactions that link mitochondria to other cellular structures and processes, such as ER-mitochondria contact sites, which are crucial for lipid transfer, calcium signaling, and maintaining mitochondrial function. Inhibitors of SYNJ2BP work by blocking its interaction with synaptojanin-2 or other binding partners, thereby disrupting the molecular pathways that rely on these interactions for proper cellular function.
The chemical structure of SYNJ2BP inhibitors varies, and they can act through different mechanisms depending on the specific target site within the SYNJ2BP protein. Some inhibitors may bind directly to the interaction domain of SYNJ2BP, preventing it from engaging with synaptojanin-2 or other proteins necessary for its role in mitochondrial function. Others may alter the conformation of SYNJ2BP, reducing its ability to participate in signaling pathways or membrane-related processes. Inhibition of SYNJ2BP can disrupt critical pathways associated with mitochondrial dynamics, including processes that regulate energy production, lipid metabolism, and cellular homeostasis. Research into SYNJ2BP inhibitors provides valuable insights into the molecular mechanisms underlying mitochondrial interactions and highlights the role of SYNJ2BP in coordinating cellular signaling networks. Understanding these inhibitors contributes to a broader knowledge of how proteins like SYNJ2BP regulate mitochondrial function and cellular integrity in response to environmental and intracellular signals.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of protein synthesis. By affecting protein synthesis, it might indirectly affect SYNJ2BP expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates DNA and inhibits RNA synthesis, potentially reducing SYNJ2BP mRNA and protein levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis. Reduced protein synthesis might lower SYNJ2BP levels. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3K). By modulating PI3K pathways, it might indirectly influence SYNJ2BP. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor. Modulation of PI3K pathways could potentially impact SYNJ2BP. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can affect chromatin structure and gene transcription, potentially influencing SYNJ2BP expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor. By affecting methylation, it might influence the transcription of genes, including SYNJ2BP. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol modulates various signaling pathways and transcription factors, which might influence SYNJ2BP expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK (c-Jun N-terminal kinases). By affecting JNK signaling, it might indirectly modulate SYNJ2BP levels. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor. Potential effects on ERK pathway could influence SYNJ2BP. | ||||||